Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (21-30 of 786) with videos related to

Pageof 79
Sort By:
Blood|April 11, 2022
T-cell-redirecting bispecific antibodies in multiple myeloma: a revolution?Philippe Moreau, Cyrille Touzeau
Blood Cancer Discovery|September 16, 2025
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging ChallengesCyrille Touzeau, Philippe Moreau
Haematologica|April 2, 2013
Multiple myeloma: so much progress, but so many unsolved questionsPhilippe Moreau, Stéphane Minvielle
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Approaches in Myeloma: Critical Trials That May Change PracticePhilippe Moreau, Cyrille Touzeau
Hematology. American Society of Hematology. Education Program|February 20, 2015
All transplantation-eligible patients with myeloma should receive ASCT in first responsePhilippe Moreau, Michel Attal
Blood|December 19, 2015
How I treat extramedullary myelomaCyrille Touzeau, Philippe Moreau
Leukemia & Lymphoma|November 30, 2012
Extramedullary multiple myeloma: extraosseous relapse is extra "bad news," but why?Philippe Moreau, Aaron Polliack
Seminars in Oncology|October 19, 2013
Initial treatment of transplant candidates with multiple myelomaPhilippe Moreau, Cyrille Touzeau
Future Oncology (London, England)|June 11, 2016
Pomalidomide in the management of relapsed multiple myelomaCyrille Touzeau, Philippe Moreau
Blood|July 1, 2021
Sensitivity to venetoclax: the B-side of myeloma?Cyrille Touzeau, Philippe Moreau
Pageof 79

Showing results (21-30 of 786) with videos related to

Sort By:
Pageof 79
Blood|April 11, 2022
T-cell-redirecting bispecific antibodies in multiple myeloma: a revolution?Philippe Moreau, Cyrille Touzeau
Blood Cancer Discovery|September 16, 2025
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging ChallengesCyrille Touzeau, Philippe Moreau
Haematologica|April 2, 2013
Multiple myeloma: so much progress, but so many unsolved questionsPhilippe Moreau, Stéphane Minvielle
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Approaches in Myeloma: Critical Trials That May Change PracticePhilippe Moreau, Cyrille Touzeau
Hematology. American Society of Hematology. Education Program|February 20, 2015
All transplantation-eligible patients with myeloma should receive ASCT in first responsePhilippe Moreau, Michel Attal
Blood|December 19, 2015
How I treat extramedullary myelomaCyrille Touzeau, Philippe Moreau
Leukemia & Lymphoma|November 30, 2012
Extramedullary multiple myeloma: extraosseous relapse is extra "bad news," but why?Philippe Moreau, Aaron Polliack
Seminars in Oncology|October 19, 2013
Initial treatment of transplant candidates with multiple myelomaPhilippe Moreau, Cyrille Touzeau
Future Oncology (London, England)|June 11, 2016
Pomalidomide in the management of relapsed multiple myelomaCyrille Touzeau, Philippe Moreau
Blood|July 1, 2021
Sensitivity to venetoclax: the B-side of myeloma?Cyrille Touzeau, Philippe Moreau
Pageof 79